Paradoxical regulation of SP1 transcription factor by glucagon

Endocrinology

Volumn 143, Issue 4, 2002, Pages 1512-1520

  Keembiyehetty, Chithra N ^a   Candelaria, Rosalind P ^a   Majumdar, Gipsy ^a,b   Raghow, Rajendra ^a   Martinez Hernandez, Antonio ^a,b   Solomon, Solomon S ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CYCLIC AMP; GLUCAGON; INSULIN; PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR SP1; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GLYCOSYLATION; HEPATOMA CELL; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0036218020     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.4.8756     Document Type: Article

References (31)

1. Molecular mechanisms of insulin modulated signaling and regulation of gene transcription
2. Effects of insulin and lipolytic hormones on cyclic AMP phosphodiesterase activity in normal and diabetic rat adipose tissue
3. Inhibitor of calmodulin and cAMP phosphodiesterase activity in BB rats
4. Expression of calmodulin genes is down regulated in diabetic BB rats
5. Insulin stimulated calmodulin gene expression in rat H-411E cells can be selectively blocked by antisense oligonucleotides
6. Transcription factor Sp1 is necessary for basal calmodulin gene transcription and for its selective stimulation by insulin
7. Insulin stimulates rat calmodulin gene transcription through activation of Sp1
8. Members of the Sp transcription factor family regulate rat calmodulin gene transcription
9. Insulin deprivation leads to deficiency of Sp1 transcription factor in H-411E hepatoma cells and in streptozotocin-induced diabetic ketoacidosis in the rat
10. The role of insulin and glucagon in the regulation of basal glucose production in the post-absorptive dog
11. Assessment of hepatic sensitivity to glucagon in NIDDM: Use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis
12. Methods for electron immunohistochemistry
13. Immunological approaches to the identification of extracellular matrix components in tissues and cell cultures
14. Tumor necrosis factor and insulin resistance: Specificity of sequence accounts of inhibition of insulin action
15. Identification of specific sites in the TNF-α molecule promoting insulin resistance in H-411E cells
16. Context-dependent transcriptional regulation
17. Repressive effect of Sp1 on the C/EBPα gene promoter: Role in adipocyte differentiation
18. Role of Sp1 in cAMP-dependent transcriptional regulation of the Bovine CYPIIA gene
19. Molecular basis of insulin action
20. Specificity and mechanism of action of some commonly used protein kinase inhibitors
21. Protein-protein interaction in insulin signaling and molecular mechanisms of insulin resistance
22. The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathway in insulin and glucagon regulation of CYP2E1 expression
23. Pioglitazone and Metformin reverse insulin resistance induced by tumor necrosis factor-α in liver cells
24. The regulation of transcription by phosphorylation
25. Nuclear protein phosphorylation and growth control
26. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase
27. O-glycosylation of eukaryotic transcription factors: Implication for mechanisms of transcriptional regulation
28. Interaction of transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62
29. Impairment by interleukin 1 beta and tumor necrosis factor α of the glucagon-induced increase in phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis in cultured rat hepatocytes
30. Reduced O-glycosylation of Sp1 is associated with increased proteosome susceptibility
31. Hyperglycemia-induced mitochondrial superoxide over-production activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation